WHO initiates prequalification of active pharmaceutical ingredients
M
The Swedish Medical Product Ag
The WHO Prequalification of Medicines Programme has posted on its website revised WHO Good Practices for Pharmaceutical Quality Control Laboratories, Annex 1 (WHO T
Following re-inspection of Sandoz SA (pty) Ltd, Kempton Park site in South Africa, the WHO Prequalification of Medicines Programme has
In accordance with the provisions set out in sec
Following corrective actions taken by Matrix Laboratories Ltd and the clarifications provided being
WHO is aware of the recent actions taken by the USA Food and Drug Administration (FDA) against the Ranbaxy, Paonta Sahib, India manufacturing site.